Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohort
{{output}}
Anti-IgLON5 disease presents with diverse symptoms, whose severity can be measured by the anti-IgLON5 disease composite score (ICS). This study applied the ICS to a retrospective anti-IgLON5 disease cohort (n = 52; median age 72 years, 63% male) diagnosed in t... ...
